4-84604313-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001263.4(CDS1):c.188C>T(p.Pro63Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000401 in 1,611,920 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001263.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CDS1 | NM_001263.4 | c.188C>T | p.Pro63Leu | missense_variant | 2/13 | ENST00000295887.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CDS1 | ENST00000295887.6 | c.188C>T | p.Pro63Leu | missense_variant | 2/13 | 1 | NM_001263.4 | P1 | |
CDS1 | ENST00000511298.1 | c.118-5116C>T | intron_variant, NMD_transcript_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.000217 AC: 33AN: 152126Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000255 AC: 64AN: 251262Hom.: 0 AF XY: 0.000280 AC XY: 38AN XY: 135800
GnomAD4 exome AF: 0.000420 AC: 613AN: 1459676Hom.: 1 Cov.: 29 AF XY: 0.000414 AC XY: 301AN XY: 726322
GnomAD4 genome AF: 0.000217 AC: 33AN: 152244Hom.: 0 Cov.: 32 AF XY: 0.000255 AC XY: 19AN XY: 74444
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 11, 2021 | The c.188C>T (p.P63L) alteration is located in exon 2 (coding exon 2) of the CDS1 gene. This alteration results from a C to T substitution at nucleotide position 188, causing the proline (P) at amino acid position 63 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at